Amin Sharifan, PharmD
Wissenschaftlicher Mitarbeiter - Department für Evidenzbasierte Medizin und Evaluation
-
amin.sharifan@donau-uni.ac.at
-
+43 2732 893-5399
-
Zum Kontaktformular
- Universität für Weiterbildung Krems
- Department für Evidenzbasierte Medizin und Evaluation
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Funktionen
Amin Sharifan ist als wissenschaftlicher Mitarbeiter und PhD-Student für Projekte im Bereich der evidenzbasierten Medizin zuständig.
Projekte (Auszug Forschungsdatenbank)
Laufende Projekte
Projektzeitraum: 01.08.2025–31.01.2026
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Projektzeitraum: 01.08.2025–31.01.2026
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Projektzeitraum: 15.07.2025–31.01.2026
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Fördergeber: andere internationale Organisationen
Projektzeitraum: 01.04.2025–31.03.2028
Projektverantwortung (Universität für Weiterbildung Krems): Amin Sharifan
Fördergeber: Bundesländer (inkl. deren Stiftungen und Einrichtungen)
Evidence Review on Pharmacologic Treatment of Chronic Insomnia
Projektzeitraum: 01.03.2025–28.02.2027
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Fördergeber: Sonstige
Projektzeitraum: 01.12.2024–30.09.2025
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Projektzeitraum: 01.11.2024–30.04.2025
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Update of a Rapid Review on Outpatient Treat-ment of Confirmed COVID-19 (Version 3)
Projektzeitraum: 01.09.2024–30.09.2025
Projektverantwortung (Universität für Weiterbildung Krems): Isolde Sommer
Fördergeber: Sonstige
Interpretation of Non-significant Differences
Projektzeitraum: 01.12.2022–31.12.2024
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Publikationen (Auszug Forschungsdatenbank)
Abdulazeem, H.; Borges do Nascimento, I.J.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Cunningham, C.; Kularathne, I.; Deeken, G.; de Barros, J.; Sathian, B.; Østengaard, L.; Lamontagne-Godwin, F.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Alistair Dos Santos, R.; Azzopardi-Muscat, N.; Yon, Y.; Novillo-Ortiz, D. (2025). Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report. JMIR Ment Health, 12:e64445: 10.2196/64445
Dobrescu, A.; Nussbaumer-Streit, B.; Wagner, G.; Sharifan, A.; Gadinger, A.; Klerings, I.; Nowak, C.; Gartlehner, G. (2025). Assessing the Impact of Unpublished Data on Network Meta-Analysis Outcomes in Outpatient Adults with Acute Migraine: A Study within a Review. Journal of Clinical Epidemiology, 112014: https://doi.org/10.1016/j.jclinepi.2025.112014
Feigin, V. L. ; Vos, T.; Nair, B. S.; Hay, S. I.; Abate, Y. H.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, 10: e203-27
GBD 2021 Europe Life Expectancy Collaborators; Steel, N., Sharifan, A. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health, 10: e172–88
GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators (2025). Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage. The Global Burden of Disease Study 2021. JAMA Neurology, 10.1001/jamaneurol.2025.1522: E1-E23
GBD 2021 Headache Collaborators; Sharifan, A. (2025). Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021. Cell Reports Medicine, 6, 10: 102348
GBD 2021 Suicide Collaborators; Davis Weaver, N.; Sharifan, A.; (2025). Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 10: e189-e202
GBD 2023 Cancer Collaborators; Sharifan, A. (2025). The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 406, 10512: P1565-1586
Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators; Sharifan, A. (2025). Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. The Journal of the American College of Cardiology (JACC), Article in press: https://doi.org/10.1016/j.jacc.2025.08.015
Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260
Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260
Kerr, J. A.; Patton, G. C.; Cini, K. I.; Abate, Y. H.; Abbas, N.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 785-812
Li, S.; Zhang, L.; Wang, Y.; Xie, R.; Chen, W.; Soo Lee, M.; Amer, Y.S.; Sharifan, A.; Hussein, H.; Li, H. (2025). Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Frontiers in Pharmacology, 16:1501634: 10.3389/fphar.2025.1501634
M. Ng,; E. Gakidou,; J. Lo,; Y. H. Abate,; C. Abbafati,; N. Abbas,; et al. (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 813-38
Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904
Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904
Oh, J.; Kim, S.; Kim, M. S.; Abate, Y. H.; Abd ElHafeez, S.; Abdelkader, A.; et al. (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13, 5: 425-446
Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395
Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395
Romantski, O.; Sharifan, A.; Fiander, M.; Ng, E.; Bruschettini, M.; supported by the Cochrane Neonatal Review Group and Cochrane Sweden (2025). Midazolam for sedation of infants in the neonatal intensive care unit (Review). Cochrane Database of Systematic Reviews, Issue 7.: Art. No.: CD002052.
Tags